Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-31

Clinical Trial Update: Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating azithromycin plus doxycycline versus doxycycline plus placebo for Rocky Mountain spotted fever.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Doxycycline (Doxycycline)

Snippet

Sponsor: Hospital General de Mexicali | Conditions: Rocky Mountain Spotted Fever | Phase 3 | Status: UNKNOWN